Biblio

Export 23 results:
Author Keyword Title [ Type(Desc)] Year
Filters: Author is van der Flier, Wiesje M  [Clear All Filters]
Journal Article
W. M. van der Flier and Scheltens, P., Amsterdam Dementia Cohort: Performing Research to Optimize Care., J Alzheimers Dis, vol. 62, no. 3, pp. 1091-1111, 2018.
R. E. R. Slot, Van Harten, A. C., Kester, M. I., Jongbloed, W., Bouwman, F. H., Teunissen, C. E., Scheltens, P., Veerhuis, R., and van der Flier, W. M., Apolipoprotein A1 in Cerebrospinal Fluid and Plasma and Progression to Alzheimer's Disease in Non-Demented Elderly., J Alzheimers Dis, vol. 56, no. 2, pp. 687-697, 2017.
S. L. C. Geijselaers, Aalten, P., Ramakers, I. H. G. B., De Deyn, P. Paul, Heijboer, A. C., Koek, H. L., OldeRikkert, M. G. M., Papma, J. M., Reesink, F. E., Smits, L. L., Stehouwer, C. D. A., Teunissen, C. E., Verhey, F. R. J., van der Flier, W. M., and Biessels, G. Jan, Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease., J Alzheimers Dis, vol. 61, no. 1, pp. 309-320, 2018.
I. van Steenoven, Aarsland, D., Weintraub, D., Londos, E., Blanc, F., van der Flier, W. M., Teunissen, C. E., Mollenhauer, B., Fladby, T., Kramberger, M. G., Bonanni, L., and Lemstra, A. W., Cerebrospinal Fluid Alzheimer's Disease Biomarkers Across the Spectrum of Lewy Body Diseases: Results from a Large Multicenter Cohort., J Alzheimers Dis, vol. 54, no. 1, pp. 287-95, 2016.
O. N. Groeneveld, Moneti, C., Heinen, R., de Bresser, J., Kuijf, H. J., Exalto, L. G., Boomsma, J. M. F., L Kappelle, J., Barkhof, F., Prins, N. D., Scheltens, P., van der Flier, W. M., and Biessels, G. Jan, The Clinical Phenotype of Vascular Cognitive Impairment in Patients with Type 2 Diabetes Mellitus., J Alzheimers Dis, vol. 68, no. 1, pp. 311-322, 2019.
E. Coart, Barrado, L. García, Duits, F. H., Scheltens, P., van der Flier, W. M., Teunissen, C. E., van der Vies, S. M., and Burzykowski, T., Correcting for the Absence of a Gold Standard Improves Diagnostic Accuracy of Biomarkers in Alzheimer's Disease., J Alzheimers Dis, 2015.
J. Barnes, Bartlett, J. W., Wolk, D. A., van der Flier, W. M., and Frost, C., Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease., J Alzheimers Dis, vol. 64, no. 2, pp. 631-642, 2018.
M. Muurling, Rhodius-Meester, H. F. M., Pärkkä, J., van Gils, M., Frederiksen, K. S., Bruun, M., Hasselbalch, S. G., Soininen, H., Herukka, S. - K., Hallikainen, M., Teunissen, C. E., Visser, P. Jelle, Scheltens, P., van der Flier, W. M., Mattila, J., Lötjönen, J., and de Boer, C., Gait Disturbances are Associated with Increased Cognitive Impairment and Cerebrospinal Fluid Tau Levels in a Memory Clinic Cohort., J Alzheimers Dis, vol. 76, no. 3, pp. 1061-1070, 2020.
E. Louwersheimer, M Keulen, A., Steenwijk, M. D., Wattjes, M. P., Jiskoot, L. C., Vrenken, H., Teunissen, C. E., van Berckel, B. N. M., van der Flier, W. M., Scheltens, P., van Swieten, J. C., and Pijnenburg, Y. A. L., Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 581-90, 2016.
H. F. M. Rhodius-Meester, Koikkalainen, J., Mattila, J., Teunissen, C. E., Barkhof, F., Lemstra, A. W., Scheltens, P., Lötjönen, J., and van der Flier, W. M., Integrating Biomarkers for Underlying Alzheimer's Disease in Mild Cognitive Impairment in Daily Practice: Comparison of a Clinical Decision Support System with Individual Biomarkers., J Alzheimers Dis, vol. 50, no. 1, pp. 261-70, 2016.
A. Hafkemeijer, Möller, C., Dopper, E. G. P., Jiskoot, L. C., van den Berg-Huysmans, A. A., van Swieten, J. C., van der Flier, W. M., Vrenken, H., Pijnenburg, Y. A. L., Barkhof, F., Scheltens, P., van der Grond, J., and Rombouts, S. A. R. B., A Longitudinal Study on Resting State Functional Connectivity in Behavioral Variant Frontotemporal Dementia and Alzheimer's Disease., J Alzheimers Dis, vol. 55, no. 2, pp. 521-537, 2017.
W. A. Krudop, Dols, A., Kerssens, C. J., Eikelenboom, P., Prins, N. D., Möller, C., Schouws, S., Rhebergen, D., van Exel, E., van der Flier, W. M., Sikkes, S., Scheltens, P., Stek, M. L., and Pijnenburg, Y. A. L., The Pitfall of Behavioral Variant Frontotemporal Dementia Mimics Despite Multidisciplinary Application of the FTDC Criteria., J Alzheimers Dis, vol. 60, no. 3, pp. 959-975, 2017.
S. Hendriks, Peetoom, K., Tange, H., van Bokhoven, M. A., van der Flier, W. M., Bakker, C., Papma, J. M., Koopmans, R., Verhey, F., Köhler, S., and de Vugt, M., Pre-Diagnostic Symptoms of Young-Onset Dementia in the General Practice up to Five Years Before Diagnosis., J Alzheimers Dis, 2022.
N. M. E. Scheltens, Tijms, B. M., Heymans, M. W., Rabinovici, G. D., Cohn-Sheehy, B. I., Miller, B. L., Kramer, J. H., Wolfsgruber, S., Wagner, M., Kornhuber, J., Peters, O., Scheltens, P., and van der Flier, W. M., Prominent Non-Memory Deficits in Alzheimer's Disease Are Associated with Faster Disease Progression., J Alzheimers Dis, 2018.
A. F. N. Rosenberger, Hilhorst, R., Coart, E., Barrado, L. García, Naji, F., Rozemuller, A. J. M., van der Flier, W. M., Scheltens, P., Hoozemans, J. J. M., and van der Vies, S. M., Protein Kinase Activity Decreases with Higher Braak Stages of Alzheimer's Disease Pathology., J Alzheimers Dis, vol. 49, no. 4, pp. 927-43, 2016.
E. Louwersheimer, Cohn-Hokke, P. E., Pijnenburg, Y. A. L., Weiss, M. M., Sistermans, E. A., Rozemuller, A. J., Hulsman, M., van Swieten, J. C., van Duijn, C. M., Barkhof, F., Koene, T., Scheltens, P., van der Flier, W. M., and Holstege, H., Rare Genetic Variant in SORL1 May Increase Penetrance of Alzheimer's Disease in a Family with Several Generations of APOE-ɛ4 Homozygosity., J Alzheimers Dis, vol. 56, no. 1, pp. 63-74, 2017.
H. Ulugut Erkoyun, van der Lee, S. J., Nijmeijer, B., van Spaendonk, R., Nelissen, A., Scarioni, M., Dijkstra, A., Samancı, B., Gürvit, H., Yıldırım, Z., Tepgeç, F., Bilgic, B., Barkhof, F., Rozemuller, A., van der Flier, W. M., Scheltens, P., Cohn-Hokke, P., and Pijnenburg, Y., The Right Temporal Variant of Frontotemporal Dementia Is Not Genetically Sporadic: A Case Series., J Alzheimers Dis, vol. 79, no. 3, pp. 1195-1201, 2021.
L. D. Van Mierlo, Wouters, H., Sikkes, S. A. M., van der Flier, W. M., Prins, N. D., Bremer, J. A. E., Koene, T., and Van Hout, H. P. J., Screening for Mild Cognitive Impairment and Dementia with Automated, Anonymous Online and Telephone Cognitive Self-Tests., J Alzheimers Dis, vol. 56, no. 1, pp. 249-259, 2017.
M. J. R. J. Bouts, Möller, C., Hafkemeijer, A., van Swieten, J. C., Dopper, E., van der Flier, W. M., Vrenken, H., Wink, A. Meije, Pijnenburg, Y. A. L., Scheltens, P., Barkhof, F., Schouten, T. M., de Vos, F., Feis, R. A., van der Grond, J., de Rooij, M., and Rombouts, S. A. R. B., Single Subject Classification of Alzheimer's Disease and Behavioral Variant Frontotemporal Dementia Using Anatomical, Diffusion Tensor, and Resting-State Functional Magnetic Resonance Imaging., J Alzheimers Dis, vol. 62, no. 4, pp. 1827-1839, 2018.
E. A. J. Willemse, Durieux-Lu, S., van der Flier, W. M., Pijnenburg, Y. A. L., de Jonge, R., and Teunissen, C. E., Stability of Progranulin Under Pre-Analytical Conditions in Serum and Cerebrospinal Fluid., J Alzheimers Dis, vol. 53, no. 1, pp. 107-16, 2016.
M. D. Zwan, Villemagne, V. L., Doré, V., Buckley, R., Bourgeat, P., Veljanoski, R., Salvado, O., Williams, R., Margison, L., Rembach, A., S Macaulay, L., Martins, R., Ames, D., van der Flier, W. M., Ellis, K. A., Scheltens, P., Masters, C. L., and Rowe, C. C., Subjective Memory Complaints in APOEɛ4 Carriers are Associated with High Amyloid-β Burden., J Alzheimers Dis, vol. 49, no. 4, pp. 1115-22, 2016.
W. M. Freeze, Jacobs, H. I. L., Gronenschild, E. H., Jansen, J. F. A., Burgmans, S., Aalten, P., Clerx, L., Vos, S. J., van Buchem, M. A., Barkhof, F., van der Flier, W. M., Verbeek, M. M., Rikkert, M. Olde, Backes, W. H., and Verhey, F. R., White Matter Hyperintensities Potentiate Hippocampal Volume Reduction in Non-Demented Older Individuals with Abnormal Amyloid-β., J Alzheimers Dis, vol. 55, no. 1, pp. 333-342, 2017.
J. Reimand, Groot, C., Teunissen, C. E., Windhorst, A. D., Boellaard, R., Barkhof, F., Nazarenko, S., van der Flier, W. M., van Berckel, B. N. M., Scheltens, P., Ossenkoppele, R., and Bouwman, F., Why Is Amyloid-β PET Requested After Performing Cerebrospinal Fluid Biomarkers?, J Alzheimers Dis, vol. 73, no. 2, pp. 559-569, 2019.